Concourse Financial Group Securities, Inc. Volitionrx LTD Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding VNRX
# of Institutions
29Shares Held
24.1MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY11.7MShares$4.56 Million5.2% of portfolio
-
Armistice Capital, LLC New York, NY8.49MShares$3.31 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$596,7180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$298,3070.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$201,2680.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $22.3M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...